FDA rais­es con­cerns over ef­fi­ca­cy of Mer­ck­'s po­ten­tial chron­ic cough drug ahead of ad­comm

The FDA’s Pul­monary-Al­ler­gy Drugs Ad­vi­so­ry Com­mit­tee will meet Fri­day to dis­cuss Mer­ck’s ap­pli­ca­tion for its chron­ic cough oral drug gefapix­ant, with the agency say­ing the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.